See other companies on Welcome to the Jungle
Mendel.ai
AI-driven oncology research
- 101-200 employees
- Healthcare
- B2B
- Artificial Intelligence
- Analytics
- SaaS
- Data Analysis
- Downtown San Jose, San Jose, CA
Jump to section
Company mission
To use AI aided by clinical experts to streamline global oncology research by organizing real world data and automating clinical trials.
Our take
Mendel is a company of physicians and engineers, that improves medical research by adding huge swathes of previously untapped data into the clinical research process. It works by transforming unstructured EMR data and clinical literature into comprehensive, compliant analytics-ready data.
Targeting medicine directly is what enables the company to stand out, alongside its smart navigation of data-privacy regulations. Mendel is able to de-identify personal health information with an over 99% accuracy rate - making a great option rivals such as DeepMind who lost traction due to privacy violations.
With impressive funding at its back, Mendel can be expected to pursue further growth in the coming years. In 2024 it made its platform available through both Google Cloud Marketplace and Microsoft Azure Marketplace, which should support a broader reach for the company.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Work from home opportunities
- Health insurance
- Flexible Spending Account (FSA)
- Dependent Care FSA
- Health Savings Account (HSA)
- Long-Term Disability
- Life Insurance
- 401k
- Maternity + Paternity Leave
Funding (last 2 of 5 rounds)
Apr 2022
$40m
SERIES B
Jun 2021
$18m
SERIES A
Total funding: $65.4m
This company has top investors
Leadership
Wael Salloum, PhD
(Founder & Chief Science Officer)Studied Computer Science at Columbia. Has worked at various universities, including as a Project Supervisor at the University of Damascus. Co-founded Lifeboon.com, and MedTools.com, and was a Senior Research Scientist at EMR.AI.
Articles
Jobs (4)
Data
Sales & Account Management